UNSPSC 85491922: Supplement left pulmonary artery with zooplastic tissue, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement left pulmonary artery with zooplastic tissue, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 02UR48Z

UNSPSC 85491922 Supplement left pulmonary artery with zooplastic tissue, percutaneous endoscopic approach is a Commodity code that shows little relevant recent state and local procurement activity. The code's nominal scope—a highly specific surgical procedure involving zooplastic tissue augmentation of the left pulmonary artery—does not align with the recent opportunities tagged under it. The opportunities instead reflect broad healthcare administrative and clinical staffing services, including independent medical evaluations for disability determinations, occupational health surveillance, pharmacy benefit management, surgical Center of Excellence networks, temporary clinical staffing, and specialty medical services for detained youth. None of these services involves the specialized cardiothoracic or vascular surgical intervention the code describes, indicating a classification mismatch rather than genuine procurement activity under the code's intended scope.

State and local buyers posting opportunities under this code include municipal pension boards (City of Phoenix), county health systems (County of Santa Clara, Harris County Juvenile Probation Department, Collier County), state transportation agencies (Washington State Department of Transportation), and cities (City of Long Beach). Recent opportunities span Arizona, California, Florida, Texas, and Washington, with response dates ranging from September 2026 through April 2026 (the Collier County pharmacy benefit management RFP due date appears inverted in the source). The mismatch between the code's surgical specificity and the administrative and ancillary clinical services actually being procured suggests this code is either misapplied by these jurisdictions or represents data classification error rather than active market demand for supplemental pulmonary artery procedures.